Santa Monica Partners LP Lixte Biotechnology Holdings, Inc. Transaction History

Santa Monica Partners LP

  • $170 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
BUY
$0.72 - $58.7 $120,000 - $9.78 Million
166,667 New
166,667 $528,000

About LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT Quotes by TradingView
  • Ticker LIXT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,646,600
  • Market Cap $33M
  • Description
  • Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agent...
More about LIXT
Track This Portfolio

Track Santa Monica Partners LP Portfolio

Follow Santa Monica Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Santa Monica Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Santa Monica Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email